High Tide Secures Majority Stake in Remexian Pharma, Expanding into Europe's Cannabis Market

2025-09-02 12:31:18 ET

High Tide Inc. ( HITI ), a retail cannabis enterprise has officially closed its previously announced acquisition of a 51% interest in Remexian Pharma GmbH , marking the company's entry into Europe's regulated cannabis market.

The transaction, valued at an estimated EUR26.4 million for the initial majority stake, implies a EUR53.4 million enterprise value for Remexian. The purchase price was satisfied through a combination of EUR7.65 million in cash, EUR7.65 million in a loan to sellers, and 5.86 million High Tide shares valued at EUR11.1 million. The final valuation will be confirmed within 30 days once Remexian's closing balance sheet is finalized.

Under the agreement, High Tide also secured a five-year call option to acquire the remaining 49% of Remexian, while Remexian's owners hold a corresponding put option. These terms allow flexibility in structuring full ownership while linking valuation to Remexian's performance.

Remexian, based in Germany, operates within Europe's largest federally regulated cannabis market. The acquisition further diversifies High Tide's revenue base beyond Canada and positions the company for long-term expansion across emerging regulated markets in Europe.

The post High Tide Secures Majority Stake in Remexian Pharma, Expanding into Europe's Cannabis Market appeared first on PRISM MarketView .

COMTEX_468498661/2927/2025-09-02T11:31:18